Literature DB >> 9673389

DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.

A Barletta1, F Marzullo, A Pellecchia, S Montemurro, A Labriola, R Lomonaco, L Grammatica, A Paradiso.   

Abstract

BACKGROUND: The cancerogenic process of colorectal cancer depends on a series of events involving oncogenes and inactivation of suppressor genes. This study concerns changes in DNA content, p53 and PCNA expression in human colon in dysplastic, precancerous and cancerous tissues.
MATERIALS AND METHODS: These characteristics were analyzed in a series of hyperplastic polyps (HP), adenomas (AD), adenocarcinomas evolved within adenomas (AC-AD) and adenocarcinomas (AC) of the large bowel. DNA ploidy was analyzed by flow cytometry and PCNA and p53 expression was evaluated by immunohistochemistry using monoclonal antibodies PC10 and PAb 1801.
RESULTS: Aneuploidy was found in 43/67 (64%) of AC and only occasionally in other subgroups (AC vs all other groups: 64% vs 99%; p = 0.00002). PCNA positivity gradually increased in the sequence from HP to AC and were significantly higher in AC compared to HP (90% vs 44%; p = 0.00007). p53 positive cells were found in 67% of AC while only occasionally in other groups (HP vs AC: p = 0.0002, AD (low dysplasia) vs AC: p = 0.001; AD (moderate dysplasia) vs AC: p = 0.001).
CONCLUSIONS: These results demonstrated a progressive immunoreactivity for PCNA in the HP to AC sequence, while p53 positivity and aneuploidy seemed specific for colon carcinoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673389

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.

Authors:  Janine G Einspahr; Maria Elena Martinez; Ruiyun Jiang; Chiu-Hsieh Hsu; Asif Rashid; Achyut K Bhattacharrya; Dennis J Ahnen; Elizabeth T Jacobs; P Scott Houlihan; C Renee Webb; David S Alberts; Stanley R Hamilton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

2.  Immunohistochemical analysis of candidate gene product expression in the duodenal epithelium of children with coeliac sprue.

Authors:  I Barshack; I Goldberg; Y Chowers; B Weiss; A Horowitz; J Kopolovic
Journal:  J Clin Pathol       Date:  2001-09       Impact factor: 3.411

3.  Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancer.

Authors:  R R Plentz; S U Wiemann; P Flemming; P N Meier; S Kubicka; H Kreipe; M P Manns; K L Rudolph
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

4.  Molecular characteristics of serrated adenomas of the colorectum.

Authors:  E J Sawyer; A Cerar; A M Hanby; P Gorman; M Arends; I C Talbot; I P M Tomlinson
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

5.  Cardiomyogenesis in the aging and failing human heart.

Authors:  Jan Kajstura; Marcello Rota; Donato Cappetta; Barbara Ogórek; Christian Arranto; Yingnan Bai; João Ferreira-Martins; Sergio Signore; Fumihiro Sanada; Alex Matsuda; James Kostyla; Maria-Virginia Caballero; Claudia Fiorini; David A D'Alessandro; Robert E Michler; Federica del Monte; Toru Hosoda; Mark A Perrella; Annarosa Leri; Bruce A Buchholz; Joseph Loscalzo; Piero Anversa
Journal:  Circulation       Date:  2012-09-06       Impact factor: 29.690

6.  Clonal evolution and therapeutic resistance in solid tumors.

Authors:  Michael T Barrett; Elizabeth Lenkiewicz; Lisa Evers; Tara Holley; Christian Ruiz; Lukas Bubendorf; Aleksander Sekulic; Ramesh K Ramanathan; Daniel D Von Hoff
Journal:  Front Pharmacol       Date:  2013-01-28       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.